pyridostigmine bromide has been researched along with ranitidine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Breyer-Pfaff, U; Eiermann, B; Maier, U; Schumm, F; Sommer, N; Winne, D | 1 |
| Kucheriavykh, LE; Nozdrachev, AD; Skopichev, VG | 1 |
| Hasan, MY; Nagelkerke, N; Nurulain, SM; Petroianu, GA; Shafiullah, M; Sheen, R | 1 |
| Hasan, MY; Kuča, K; Lorke, DE; Nurulain, SM; Petroianu, GA; Shafiullah, M | 2 |
| Hasan, MY; Kuča, K; Lorke, DE; Nurulain, SM; Petroianu, GA | 2 |
10 other study(ies) available for pyridostigmine bromide and ranitidine
| Article | Year |
|---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Renal clearance of pyridostigmine in myasthenic patients and volunteers under the influence of ranitidine and pirenzepine.
Topics: Adolescent; Adult; Aged; Drug Interactions; Female; Glomerular Filtration Rate; Humans; Kidney Glomerulus; Kidney Tubules; Male; Middle Aged; Myasthenia Gravis; Pirenzepine; Pyridostigmine Bromide; Ranitidine | 1993 |
[Effects of acetylcholine and histamine on leukocyte and neutrophil numbers in the endometrium of rats in various phases of the estrous cycle (by imprints)].
Topics: Acetylcholine; Animals; Atropine; Carbamates; Carbolines; Cell Count; Cholinesterase Inhibitors; Diestrus; Endometrium; Estrus; Female; Histamine; Histamine H1 Antagonists; Histamine H2 Antagonists; Lymphocytes; Muscarinic Antagonists; Neuroimmunomodulation; Neutrophils; Pyridines; Pyridostigmine Bromide; Ranitidine; Rats; Rats, Wistar | 2000 |
Ranitidine in acute high-dose organophosphate exposure in rats: effect of the time-point of administration and comparison with pyridostigmine.
Topics: Animals; Dose-Response Relationship, Drug; Drug Interactions; Erythrocytes; Organophosphorus Compounds; Prospective Studies; Pyridostigmine Bromide; Ranitidine; Rats; Time Factors | 2006 |
Pretreatment for acute exposure to diisopropylfluorophosphate: in vivo efficacy of various acetylcholinesterase inhibitors.
Topics: Amiloride; Animals; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Erythrocytes; Female; Humans; Inhibitory Concentration 50; Isoflurophate; Male; Methylene Blue; Metoclopramide; Oximes; Physostigmine; Proportional Hazards Models; Pyridinium Compounds; Pyridostigmine Bromide; Ranitidine; Rats; Tacrine; Tiapride Hydrochloride | 2011 |
Usefulness of administration of non-organophosphate cholinesterase inhibitors before acute exposure to organophosphates: assessment using paraoxon.
Topics: Animals; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Lethal Dose 50; Male; Organophosphate Poisoning; Oximes; Paraoxon; Physostigmine; Pyridostigmine Bromide; Ranitidine; Rats; Rats, Wistar; Tacrine; Tiapride Hydrochloride | 2013 |
Reversible cholinesterase inhibitors as pre-treatment for exposure to organophosphates: assessment using azinphos-methyl.
Topics: Animals; Azinphosmethyl; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Male; Oximes; Physostigmine; Proportional Hazards Models; Pyridinium Compounds; Pyridostigmine Bromide; Ranitidine; Rats; Rats, Wistar; Tacrine | 2015 |
Combined Pre- and Posttreatment of Paraoxon Exposure.
Topics: Animals; Cholinesterase Inhibitors; Cholinesterase Reactivators; Male; Organophosphates; Oximes; Paraoxon; Physostigmine; Post-Exposure Prophylaxis; Pre-Exposure Prophylaxis; Proportional Hazards Models; Pyridostigmine Bromide; Ranitidine; Rats; Rats, Wistar; Survival Analysis; Tacrine | 2020 |